Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neuroblastoma × Eflornithine × Clear all

Status

Sponsor Class

Study Type

Interventional 7 Expanded_access 1

Sponsor

Cancer Type

Conditions

Typical Teratoid Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Medulloblastoma 1

Interventions

3-Iodobenzylguanidine 7 pegfilgrastim 1 omburtamab I-131 1 Vorinostat 1 Potassium Iodide 1 Ketoconazole 1 Granulocyte Colony-Stimulating Factor 1 Fenretinide 1 Eflornithine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡